{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:44:25Z","timestamp":1758401065382},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,10,12]],"date-time":"2006-10-12T00:00:00Z","timestamp":1160611200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:p> <jats:italic>\n            <jats:bold>Background:<\/jats:bold> Detailed analysis of signal\u2010averaged P waves (SAPW) can provide insights into atrial electrophysiology. Abbreviated dosing of verapamil prior to cardioversion improves outcome at 1 week postcardioversion. The mechanism by which verapamil manifests benefit is uncertain. We hypothesized the SAPW would reflect any change in atrial electrophysiologic substrate afforded by verapamil when compared with controls.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Methods:<\/jats:bold> We investigated 23 patients attending external cardioversion of persistent atrial fibrillation (AF) (6 female; mean age 68 years). Patients were randomized to verapamil 240 mg daily in three divided doses 3 days before cardioversion and 1 week after, or usual medication. SAPW recordings were performed during sinus rhythm (SR) immediately after cardioversion, at 24 hours and 1 week.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Results:<\/jats:bold> The groups were comparable in terms of age, gender, left atrial size, and duration of AF. Eight of nine patients prescribed verapamil maintained SR at 1 week postcardioversion compared with 6 of 14 controls (P = 0.027). SAPW spectral analysis delivered higher energy for patients prescribed verapamil (median (IQ range)); 40.8 (33.4\u201395.1) versus 25.7 (19.0\u201338.0) for energy within 20\u2013150 Hz, P20 (\u03bcV<jats:sup>2<\/jats:sup>\u00b7 s; P = 0.03). There was no difference in P\u2010wave duration (PWD) or root mean square of the terminal 30 ms between the two groups. Early reinitiation occurred in patients with significantly lower P\u2010wave energy 19.6 (12.9\u201324.6) versus 39.9 (24.0\u201347.0) (P = 0.017).<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Conclusions:<\/jats:bold> Verapamil 240 mg daily for 3 days prior to cardioversion and 1 week after reduces early recurrence of AF. The SAPW observations indicate change in atrial electrophysiologic substrate might be responsible for benefit afforded by verapamil.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2006.00469.x","type":"journal-article","created":{"date-parts":[[2006,10,13]],"date-time":"2006-10-13T00:56:02Z","timestamp":1160700962000},"page":"1089-1095","source":"Crossref","is-referenced-by-count":8,"title":["Signal\u2010Averaged P Wave Reflects Change in Atrial Electrophysiological Substrate Afforded by Verapamil Following Cardioversion from Atrial Fibrillation"],"prefix":"10.1111","volume":"29","author":[{"given":"DAMIAN P.","family":"REDFEARN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALLAN C.","family":"SKANES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOANNE","family":"LANE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PETER J.","family":"STAFFORD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.7.1945"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00256-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00311-7"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)80353-9"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.017707"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2001.00766.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/eupc.1999.0055"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01132-9"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2000.01231.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.09478.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1994.tb03811.x"},{"key":"e_1_2_7_13_2","first-page":"311","article-title":"Reverse atrial electrical remodelling following atrial defibrillation as determined by signal\u2010averaged ECG","volume":"20","author":"Healey JS","year":"2004","journal-title":"Can J Cardiol"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2006.00058.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016368723033"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.2143\/AC.58.2.2005266"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.118110"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb00996.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1995.tb02595.x"},{"key":"e_1_2_7_20_2","first-page":"640","article-title":"Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation","volume":"74","author":"Stafford PJ","year":"1995","journal-title":"British Heart Journal"},{"key":"e_1_2_7_21_2","first-page":"418","article-title":"Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation","volume":"74","author":"Stafford PJ","year":"1995","journal-title":"British Heart Journal"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/12.10.597"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2968"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.2.200"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1996.tb03357.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00269-9"},{"key":"e_1_2_7_27_2","volume-title":"Cardiac Electrophysiology: From Cell to Bedside","author":"Zipes DP","year":"2004"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.56.5.696"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.81.6.1045"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90381-A"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.5.1588"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1542"},{"key":"e_1_2_7_33_2","first-page":"570","article-title":"Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle","volume":"42","author":"Duff HJ","year":"1992","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00030-9"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1998.tb00209.x"},{"key":"e_1_2_7_36_2","first-page":"890","article-title":"(Abstract) The signal averaged P wave: A non\u2010invasive marker for atrial remodeling following DC cardioversion of atrial fibrillation in man?","volume":"22","author":"Spurrell P","year":"1999","journal-title":"Pacing & Clinical Electrophysiology"},{"key":"e_1_2_7_37_2","first-page":"513","article-title":"Can short\u2010term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?","volume":"2","author":"Zardo F","year":"2001","journal-title":"Italian Heart Journal: Official Journal of the Italian Federation of Cardiology"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2006.00469.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2006.00469.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T04:39:44Z","timestamp":1697085584000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2006.00469.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1111\/j.1540-8159.2006.00469.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2006.00469.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}